Tag - pharmaceuticals

 
Menu
Search
 
November 21, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

A Nigerian health official administers an mpox vaccination at Federal Medical Center in Abuja, Nigeria, on Monday.
JAPAN
Nov 20, 2024
WHO approves Japanese pharmaceutical company's mpox vaccine
The listing from the World Health Organization paves the way for countries worldwide to quickly approve and import the vaccine for distribution.
Lecanemab was developed by drugmakers Eisai of Japan and Biogen of the United States.
JAPAN / Science & Health
Nov 15, 2024
European agency switches to recommending new Alzheimer's drug
The committee judged that the efficacy of lecanemab outweighs the risk for some patients.
For patients using donanemab, it will cost them about ¥3.08 million per year. But national insurance coverage will have the government shoulder most of the cost.
JAPAN / Science & Health
Nov 13, 2024
Japan OKs insurance coverage of Alzheimer's drug donanemab
Donanemab became the second Alzheimer's drug that targets causative deposited plaque in the brain to win the coverage after lecanemab.
A pharmacist displays boxes of Ozempic in Provo, Utah.
BUSINESS
Nov 6, 2024
Obesity drug maker Novo Nordisk posts strong profit
Europe's most valuable company and the main driver of the Danish economy said it expected its 2024 full-year sales to be up by 23% to 27% from a year earlier.
Since October, patients have been asked to pay more for brand-name drugs prescribed by medical institutions if the patents have expired.
JAPAN
Nov 6, 2024
Japan raises out-of-pocket costs for off-patent drugs
With the increases, the government aims to reduce health care costs by encouraging greater use of generic drugs.
Various kinds of over-the-counter drugs seized by police after being illegally kept to be sold in Tokyo's Kabukicho entertainment district and other locations
JAPAN / Society
Nov 1, 2024
Experts call for action on OTC drug abuse among youth in Japan
A number of people have experienced organ damage, including liver failure, with some cases resulting in death.
Takeda Pharmaceutical raised its full-year operating profit guidance to ¥265 billion from ¥225 billion, citing a stronger than expected first-half performance and updated currency assumptions.
BUSINESS
Oct 31, 2024
Japan's Takeda raises full-year profit forecast amid restructuring
Takeda raised its full-year operating profit guidance to ¥265 billion from ¥225 billion, citing a stronger than expected first-half performance.
Keisuke Yoshida, a former Daiichi Sankyo employee, was sentenced to 16 years in prison on Wednesday for murdering his wife with methanol in 2022.
JAPAN / Crime & Legal
Oct 31, 2024
Ex-employee of drugmaker sentenced to 16 years for methanol murder
Tokyo District Court on Wednesday sentenced a former employee of drugmaker Daiichi Sankyo to 16 years in prison for the murder of his wife by methanol poisoning in 2022.
The winners of the Nobel Prize in Chemistry are announced in Stockholm, Sweden, on Oct. 9. They are, as seen on the display screen, David Baker (left), of the University of Washington; Demis Hassabis (center) and John M. Jumper (right), both from Google DeepMind, U.K.
COMMENTARY / World
Oct 15, 2024
Google's DeepMind Nobel Prize showcases AI’s medical potential
Google’s AlphaFold tool is already widely used by pharmaceutical researchers searching for groundbreaking new medicines.
Hiroyuki Okuzawa, chief operating officer of Daiichi Sankyo, during an interview in Tokyo on Friday
BUSINESS / Companies
Oct 11, 2024
Daiichi Sankyo eyes newer cancer drugs to stave off rivals
The Japanese drugmaker has emerged as a leader in ADC, a type of cancer therapy that targets cancerous cells while sparing the healthy ones.
Community leaders discuss the role of pre-exposure prophylaxis (PrEP) in ending the HIV/AIDS threat to public health by 2030 at a seminar hosted by Gilead Sciences in Tokyo on Sept. 25.
JAPAN / Science & Health
Oct 1, 2024
HIV prevention drug remains out of reach for many in Japan despite approval
The drug's high cost together with insufficient knowledge and awareness are hindering efforts to broaden access to it, experts and community leaders say.
Mecobalamin is a form of vitamin B12 sold as a remedy for peripheral neuropathy and other conditions. It was initially proposed for pharmaceutical approval as a treatment for ALS in 2015 by drugmaker Eisai Co. after its clinical trial found a certain level of efficacy.
JAPAN / Science & Health
Sep 24, 2024
Japan approves sale of new ALS drug, raising hopes among patients
The drug, mecobalamin, extended the survival period of patients within a year of the onset of ALS by over 500 days, surpassing existing drugs.
A scientist looks at brain scans of a patient suffering from Alzheimer's disease in Geneva in 2023.
WORLD / Science & Health
Sep 21, 2024
Revolution or mirage? Controversy surrounds new Alzheimer's drugs
For defenders, the drugs represent a real chance to fight the disease. For detractors, they are a disappointment after a long line of costly failures.
Daiichi Sankyo is working on the next generation of targeted cancer drugs.
JAPAN / Science & Health
Sep 17, 2024
Daiichi wants to go it alone in search for targeted cancer drugs
Investors are betting on Daiichi’s continued success, with its share price up 122% in the last five years.
People walk past the AstraZeneca booth during the first China International Supply Chain Expo (CISCE) in Beijing on Nov. 28, 2023.
BUSINESS / Companies
Sep 16, 2024
AstraZeneca’s blockbuster drug scores major win in combatting bladder cancer
In patients with muscle-invasive bladder cancer, the drug Imfinzi reduced the risk of disease recurring by 32% when given alongside the current standard of care.
From October, patients who choose the original versions of drugs with expired patents over their generic counterparts will shoulder higher costs.
JAPAN / Science & Health
Sep 15, 2024
Out-of-pocket costs for off-patent drugs to rise in October
Moisturizing ointments and patches are among the 1,095 items to be affected by the revision.
Hiroyuki Mano, director of the National Cancer Center Japan's (NCC) research institute, explains on Wednesday the use of mice bearing patients' cancer tissues to screen drug candidates for their efficacy.
JAPAN / Science & Health
Sep 13, 2024
New mouse models can boost Japan's drug development: National Cancer Center
The tumor-bearing mice retain many of the characteristics of the patients' cancer tissues, so favorable drug test results are likelier to be replicated in human trials.
The U.S. Patent and Trademark Office's public search facility in Alexandria, Virginia
ASIA PACIFIC
Aug 30, 2024
U.S. funded over 1,000 patents for China-based researchers, data shows
The U.S. patent data could amplify calls to cancel or renegotiate the landmark U.S.-China Science and Technology Agreement.
Although Truvada has been used globally as an HIV prevention drug for years, the movement toward expanding its use as preexposure prophylaxis in Japan has been slow.
JAPAN / Science & Health
Aug 29, 2024
Health ministry approves Truvada as HIV prevention drug
Truvada is the first drug approved in Japan for both the treatment and prevention of HIV, the virus that causes AIDS.
Japan's pharmaceutical shares have gained 10% since the start of July through last week.
BUSINESS / Companies
Aug 27, 2024
Japan's pharmaceutical stocks surge to record highs after market rout
The firms' market performance suggest investors favor defensive shares amid concern that global economic growth will slow.
Ishiba delays meeting with Trump, citing legal restrictions
Prime Minister Shigeru Ishiba waves upon arrival for the Asia-Pacific Economic Cooperation forum, in Callao, Peru, on Friday.
Two of America’s biggest debt holders are dumping Treasurys
The U.S. Treasury building in Washington. Investors in Japan and China sold a pile of U.S. debt in the last quarter, just before the U.S. presidential election.
Rising sex tourism exposes loopholes in Japan's anti-prostitution law
While financial misfortunes during the COVID-19 pandemic may have driven some women to work the streets, others simply want more money to spend — or want to pay off their debts — at host clubs.
Japan ranks last in romance satisfaction for second straight year
In a survey of 31 countries, Japan ranked last in terms of those who felt loved, with just 51% of respondents saying so.
Ruling coalition and DPP strike last-minute deal over economic policy
DPP policy chief Makoto Mahaguchi speaks at the party's policy gathering in Tokyo on Wednesday.
Japan, U.K. and Italy discuss inviting more countries to joint fighter project
A new concept model of a next-generation fighter jet to be jointly developed by Japan, Britain and Italy is on display in Farnborough, Hampshire, in July.
Haruki Murakami's 'The City and Its Uncertain Walls' gives deep deja vu
For “The City and Its Uncertain Walls,” translated into English by Philip Gabriel, Haruki Murakami confronts the ghosts who won't leave him alone.
Japanese expats in Asia find community through rugby
The Taiwan Fivewoods celebrate their victory at the 2023 Asian Japanese Rugby Cup in December of last year.
In Fukushima, a weekend of prose, poetry and translation
Aomori-based writer JJ Carter presented on tabletop gaming as creative inspiration for building characters and narratives.
For Dr. Nakamats, aging is just experience in action
Though he didn't win the recent gubernatorial election in Tokyo, the 96-year-old Dr. Nakamats' run was seen as inspirational in Japan's aging society.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

Azabudai Hills, Tokyo’s green new downtown ‘village’
Azabudai Hills, Tokyo’s green new downtown ‘village’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER